EMA launches Website for accelerating EU Clinical Trials

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
The EMA has launched a dedicated website for the Accelerating clinical trials in the European Union (ACT EU) initiative, co-led by the European Commission, the Heads of Medicines Agencies and the European Medicines Agency (EMA). The website contains updates on the progress of ACT EU priority actions, which aim to improve the clinical trials environment in the EU through harmonization, innovation, and stakeholder collaboration.
Key resources include latest information on:
- the Multi-stakeholder platform;
- the implementation of the Clinical Trials Regulation (CTR);
- voluntary procedures in scientific advice;
- the Simultaneous national scientific advice (SNSA) pilot.
In addition, the EMA held a workshop on establishing a multi-stakeholder platform on 22/23 June 2023. Following the workshop, the presentations shown and also the video recordings were published on the EMA website about the workshop.
Related GMP News
10.07.2025EMA Policy on the Publication of Clinical Data
17.06.2025EMA Implementation of ICH E6, M11 & M12
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials
03.04.2025EMA Concept Paper on Model Informed Drug Development